Status:
COMPLETED
Effect of Virtual Reality Glasses in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction
Lead Sponsor:
Mersin University
Conditions:
Arteriovenous Fistula
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This research was conducted as a randomized controlled experimental study aiming to determine the impact of virtual reality glasses used in the AVF process on the pain felt by patients and patient sat...
Detailed Description
Chronic kidney disease (CKD) is a progressive, irreversible renal disease in which the ability of the body to maintain the balance of metabolism, fluid and electrolytes fails. Chronic kidney disease (...
Eligibility Criteria
Inclusion
- Receiving HD treatment
- Open to communication
- Fully oriented
- Without vision, hearing and perception problems
- Without any psychiatric illness
- Without a history of seizures such as epilepsy
- HD treatment administered via AVF
- İn the last day, no injection was made into any artery or vein from the place where the intervention will be performed
- Without any signs of infection such as redness, swelling, open wound in the area where the intervention will be performed
- Standardized Mini Mental Test value is 24 points and above
- One-time needle attempt from AV
Exclusion
- Refusing to participate in the study
- under the age of 18
- Can't speak Turkish
- Closed to communication and not fully oriented
- Visual, hearing and perception problems
- Any psychiatric illness
- Having a history of seizures such as epilepsy
- HD treatment not administered via AVF
- Injection into any artery or vein from the place where the intervention will be performed in the last day,
- Any signs of infection such as redness, swelling, open wound in the area to be operated
- Using any pain medication before the procedure on the same day
- SMMT value below 24 in patients over 65 years of age
- Cannulation procedure not performed with a 16 G AVF needle
- Patients with multiple injections from the AVF
Key Trial Info
Start Date :
November 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05326321
Start Date
November 13 2018
End Date
January 9 2019
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mersin University
Mersin, Turkey (Türkiye), 33110